T Inokuchi Selected Research

Rare Diseases (Rare Disease)

12/2017

Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Inokuchi Research Topics

Disease

5	Body Weight (Weight, Body) 03/2006 - 01/2000
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2006 - 10/2000
3	Gout 04/2009 - 01/2006
3	Neoplasms (Cancer) 05/2001 - 01/2000
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2017 - 09/2001
2	Insulin Resistance 12/2017 - 07/2007
2	Hypertriglyceridemia 07/2007 - 01/2006
2	Carcinoma (Carcinomatosis) 07/2006 - 10/2000
2	Cicatrix (Scar) 09/2003 - 04/2002
2	Wounds and Injuries (Trauma) 09/2003 - 04/2002
2	Ganglion Cysts (Ganglion) 01/2001 - 04/2000
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2017
1	Rare Diseases (Rare Disease) 12/2017
1	Vasculitis (Vasculitides) 12/2017
1	Stroke (Strokes) 11/2015
1	Primary hyperoxaluria type 2 10/2014
1	Mouth Neoplasms (Oral Cancer) 03/2006
1	Tongue Neoplasms (Tongue Neoplasm) 03/2006
1	Chylothorax 02/2003
1	Aortic Dissection 02/2002
1	Aortic Arch Aneurysm 02/2002
1	Aneurysm (Aneurysms) 02/2002
1	Type 2 Diabetes Mellitus (MODY) 09/2001
1	Ketosis 07/2001
1	Necrosis 10/2000

Drug/Important Bio-Agent (IBA)

5	Uric Acid (Urate)IBA 04/2009 - 04/2004
2	Allopurinol (Remid)FDA LinkGeneric 04/2009 - 03/2006
2	purineIBA 10/2005 - 04/2004
2	HypoxanthineIBA 10/2005 - 04/2004
2	XanthineIBA 10/2005 - 04/2004
2	CollagenIBA 09/2003 - 04/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2003 - 04/2002
2	ParaffinIBA 05/2001 - 01/2000
2	Bromodeoxyuridine (BrdU)IBA 05/2001 - 10/2000
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2000 - 01/2000
1	Insulin ReceptorIBA 12/2017
1	AlbuminsIBA 12/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2017
1	B-insulinIBA 12/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2017
1	Insulin (Novolin)FDA Link 12/2017
1	Rituximab (Mabthera)FDA Link 12/2017
1	AntibodiesIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	Amine Oxidase (Copper-Containing)IBA 11/2015
1	Oxidoreductases (Dehydrogenase)IBA 11/2015
1	human AOC3 proteinIBA 11/2015
1	AminesIBA 11/2015
1	Hydroxypyruvate ReductaseIBA 10/2014
1	glyoxylate reductaseIBA 10/2014
1	BenzbromaroneIBA 04/2009
1	AdiponectinIBA 04/2009
1	Triglycerides (Triacylglycerol)IBA 07/2007
1	PPAR alphaIBA 07/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2006
1	Thymidylate SynthaseIBA 03/2006
1	Losartan (Cozaar)FDA LinkGeneric 01/2006
1	Fenofibrate (CiL)FDA LinkGeneric 01/2006
1	Ethanol (Ethyl Alcohol)IBA 10/2005
1	UridineIBA 04/2004
1	Molecular Chaperones (Chaperone, Molecular)IBA 09/2003
1	Antisense OligonucleotidesIBA 09/2003
1	Collagen Type I (Type I Collagen)IBA 04/2002
1	Aldehyde Reductase (Aldose Reductase)IBA 09/2001
1	epalrestatIBA 09/2001
1	AcidsIBA 07/2001
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2001
1	Hematoxylin (Haematoxylon)IBA 10/2000
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2000
1	PicibanilIBA 10/2000
1	HematoporphyrinsIBA 10/2000
1	Immunologic Factors (Immunomodulators)IBA 10/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2000
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2000
1	Fas Ligand Protein (Fas Ligand)IBA 01/2000
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2000

Therapy/Procedure

2	Therapeutics 12/2017 - 04/2009
2	Photochemotherapy (Photodynamic Therapy) 10/2000 - 01/2000
1	Bone-Anchored Prosthesis 03/2006
1	Neck Dissection (Radical Neck Dissection) 02/2003
1	Conservative Treatment 02/2003
1	Thoracotomy 02/2002
1	Oral Administration 11/2001
1	Rhizotomy 01/2001
1	Dye Lasers 01/2000